Skip to main content
. 2014 Oct 29;44(11):4884–4900. doi: 10.1039/c4dt02978j

Fig. 6. Reverse phase radiochromatogram of (A) [89Zr(CP256)]+ (black) and (B) [89Zr(DFO)]+ (dotted line); (C) A solution of [89Zr(CP256)]+ incubated with H3DFO ligand (H3CP256–H3DFO = 1 : 1, black line); (H3CP256–H3DFO = 1 : 10, blue line); (H3CP256–H3DFO = 1 : 100, red line); in all experiments, final [H3CP256] = 500 μM. (D) A solution of [89Zr(DFO)]+ incubated with H3CP256 ligand (H3DFO–H3CP256 = 1 : 1, black line); (H3DFO–H3CP256 = 1 : 10, blue line); (H3DFO–H3CP256 = 1 : 100, red line); in all experiments, final [H3DFO] = 500 μM.

Fig. 6